Bioregenx (BRGX) Accumulated Depreciation & Amortization (2023 - 2024)
Bioregenx's quarterly Accumulated Depreciation & Amortization came in at $12377.0 in Q3 2024, up 245.73% year-on-year from $3580.0 in Q4 2023, and up 61.96% quarter-over-quarter from $7642.0 in Q2 2024.
Bioregenx has reported Accumulated Depreciation & Amortization for 2 years, with the latest figure at $12377.0 in Q3 2024.
- For the quarter ending Q3 2024, Accumulated Depreciation & Amortization rose 245.73% year-over-year to $12377.0; the trailing twelve-month figure through Sep 2024 stood at $12377.0 (up 245.73% YoY), and the FY2023 full-year result was $3579.0, changed N/A from the prior year.
- Accumulated Depreciation & Amortization for Q3 2024 stood at $12377.0, up from $7642.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $20661.0 in Q1 2024, with the low at $1194.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Bioregenx | - | - | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 12,377.00 |
| Sep 30, 2024 | 12,377.00 |
| Jun 30, 2024 | 7,642.00 |
| Jun 30, 2024 | 7,642.00 |
| Mar 31, 2024 | 20,661.00 |
| Mar 31, 2024 | 20,661.00 |
| Dec 31, 2023 | 3,579.00 |
| Dec 31, 2023 | 3,579.00 |
| Sep 30, 2023 | 1,193.00 |
| Sep 30, 2023 | 1,193.00 |
| Jun 30, 2023 | 1,194.00 |
| Jun 30, 2023 | 1,194.00 |